Immunic (IMUX) Stock
Small biotech company developing immune system treatments. Here's the price, business snapshot, and what's worth knowing about Immunic in August 2026.
Immunic Inc (IMUX) is a small-cap biotechnology company with a market capitalisation of about $81.12 million. As a company in the biotech space, its prospects tend to be driven by clinical results, regulatory decisions, partnerships and financing activity rather than steady earnings. That makes IMUX inherently more speculative and often more volatile than larger, diversified firms. Investors should focus on the company’s latest regulatory filings, press releases and cash runway, since small biotechs frequently need to raise capital to fund development. Potential upside may come from positive trial readouts or strategic collaborations, while downside risks include trial failures, regulatory setbacks and dilution from new funding. This summary is educational only; it is not personal financial advice. Consider your risk tolerance and consult an authorised financial professional before making investment decisions.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Immunic Inc.'s stock with a target price of $27.05, indicating strong potential growth.
Financial Health
Immune Inc has a solid financial position with healthy cash flow and book value per share.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
Potential Growth Drivers
Clinical readouts, approvals or partnerships can materially change outlook, though these events are uncertain and can go either way.
Catalysts To Watch
Upcoming trial milestones or financing announcements are common catalysts; they may boost momentum or increase volatility.
Market & Funding Context
Small-cap biotechs often need fresh capital to progress programmes — check cash runway and dilution risk before investing.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
